Biote Corp./$BTMD
1D1W1MYTD1Y5YMAX
Capital at risk
About Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
- Ticker
- $BTMD
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 223
- Headquarters
- Irving, United States
- Website
- www.biote.com
Biote Corp. Metrics
BasicAdvanced
$39M
7.50
$0.18
1.65
-
Price and volume
Market cap
$39M
Beta
1.65
52-week high
$3.40
52-week low
$1.27
Average daily volume
289K
Financial strength
Current ratio
1.43
Quick ratio
0.63
Long term debt to equity
-2.145
Total debt to equity
-2.211
Interest coverage (TTM)
1.65%
Profitability
EBITDA (TTM)
25.484
Gross margin (TTM)
69.45%
Net profit margin (TTM)
3.19%
Operating margin (TTM)
12.33%
Effective tax rate (TTM)
30.98%
Revenue per employee (TTM)
$820,000
Management effectiveness
Return on assets (TTM)
9.33%
Return on equity (TTM)
-10.33%
Valuation
Price to earnings (TTM)
7.501
Price to revenue (TTM)
0.225
Price to book
-0.57
Price to tangible book (TTM)
-0.49
Price to free cash flow (TTM)
2.354
Free cash flow yield (TTM)
42.49%
Free cash flow per share (TTM)
0.578
Growth
Revenue change (TTM)
-7.81%
Earnings per share change (TTM)
-79.39%
3-year revenue growth (CAGR)
0.55%
3-year earnings per share growth (CAGR)
-37.55%
Upcoming events
No upcoming events
Biote Corp. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.